Office of Technology Commercialization

The Commercialization and Licensing group supports MD Anderson's mission to eliminate cancer as a health threat by accelerating the entrance of new drugs, diagnostics, devices and therapies into the commercial marketplace.

We accomplish this goal through:

• Prudent investment of Institution resources in patents
• Marketing and licensing MD Anderson ideas and inventions to industry
• The creation of new entities (start-ups)
• A long-term view of licensing income and equity value

Technologies Available for Licensing

The portfolio of technologies available for licensing changes frequently.

Please contact the Office of Technology Commercialization with a brief "wish list" of technologies and disease categories in which you have an interest.

Email our contact at: adennis@mdanderson.org, or call the Office of Technology Commercialization at (713) 745-9602.